Compile Data Set for Download or QSAR
Report error Found 207 Enz. Inhib. hit(s) with all data for entry = 10115
TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280366BDBM280366(2-(5-chloro-2-fluorophenyl)-5-cyclopropyl-N-{1H-py...)
Affinity DataIC50: 2.70nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280369BDBM280369(2-(5-chloro-2-fluorophenyl)-5-(propan-2-yl)-N-{7H-...)
Affinity DataIC50: 3.70nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280370BDBM280370(2-(5-chloro-2-fluorophenyl)-5-(propan-2-yl)-N-{1H-...)
Affinity DataIC50: 3.70nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280365BDBM280365(4-{[2-(5-chloro-2-fluorophenyl)-5-cyclopropylpyrid...)
Affinity DataIC50: 4.80nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280366BDBM280366(2-(5-chloro-2-fluorophenyl)-5-cyclopropyl-N-{1H-py...)
Affinity DataIC50: 6.10nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 514529BDBM514529(N-(2-aminoethyl)-4-[[2-(5-chloro-2-fluoro-phenyl)-...)
Affinity DataIC50: 6.80nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280369BDBM280369(2-(5-chloro-2-fluorophenyl)-5-(propan-2-yl)-N-{7H-...)
Affinity DataIC50: 8.20nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280340BDBM280340((S)-4-(2-(5-chloro-2-fluorophenyl)-5-isopropylpyri...)
Affinity DataIC50: 8.60nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280360BDBM280360(4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropenyl-4-p...)
Affinity DataIC50: 10.3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280365BDBM280365(4-{[2-(5-chloro-2-fluorophenyl)-5-cyclopropylpyrid...)
Affinity DataIC50: 10.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280363BDBM280363(2-(3-fluoropyridin-2-yl)-5-(propan-2-yl)-N-{1H-pyr...)
Affinity DataIC50: 10.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 514529BDBM514529(N-(2-aminoethyl)-4-[[2-(5-chloro-2-fluoro-phenyl)-...)
Affinity DataIC50: 11nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280360BDBM280360(4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropenyl-4-p...)
Affinity DataIC50: 11.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280348BDBM280348(N-(2-amino-2-oxo-ethyl)-4-[[2-(5-chloro-2-fluoro-p...)
Affinity DataIC50: 11.7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280341BDBM280341((S)-4-(2-(5-chloro-2-fluorophenyl)-5-(prop-1-en-2-...)
Affinity DataIC50: 13nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280348BDBM280348(N-(2-amino-2-oxo-ethyl)-4-[[2-(5-chloro-2-fluoro-p...)
Affinity DataIC50: 15.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280340BDBM280340((S)-4-(2-(5-chloro-2-fluorophenyl)-5-isopropylpyri...)
Affinity DataIC50: 15.7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280341BDBM280341((S)-4-(2-(5-chloro-2-fluorophenyl)-5-(prop-1-en-2-...)
Affinity DataIC50: 16.2nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280363BDBM280363(2-(3-fluoropyridin-2-yl)-5-(propan-2-yl)-N-{1H-pyr...)
Affinity DataIC50: 16.4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280356BDBM280356(4-[[2-amino-6-(5-chloro-2-fluoro-phenyl)-3-isoprop...)
Affinity DataIC50: 16.9nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280345BDBM280345((S)-4-(2-(5-chloro-2-fluorophenyl)-5-isopropylpyri...)
Affinity DataIC50: 17.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280370BDBM280370(2-(5-chloro-2-fluorophenyl)-5-(propan-2-yl)-N-{1H-...)
Affinity DataIC50: 17.7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280337BDBM280337((S)-4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropyl-4...)
Affinity DataIC50: 20.4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280346BDBM280346(4-[[2-(5-chloro-2-fluoro-phenyl)-5-methoxy-4-pyrid...)
Affinity DataIC50: 23.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280364BDBM280364(2-(3-fluoropyridin-2-yl)-5-(propan-2-yl)-N-{7H-pyr...)
Affinity DataIC50: 23.7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280347BDBM280347(N-(2-acetamidoethyl)-4-[[2-(5-chloro-2-fluoro-phen...)
Affinity DataIC50: 23.9nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280355BDBM280355(4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropyl-4-pyr...)
Affinity DataIC50: 24.7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280364BDBM280364(2-(3-fluoropyridin-2-yl)-5-(propan-2-yl)-N-{7H-pyr...)
Affinity DataIC50: 26.4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280361BDBM280361(4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropenyl-4-p...)
Affinity DataIC50: 28.1nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280339BDBM280339((S)-4-(2-(5-chloro-2-fluorophenyl)-5-(prop-1-en-2-...)
Affinity DataIC50: 28.1nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280345BDBM280345((S)-4-(2-(5-chloro-2-fluorophenyl)-5-isopropylpyri...)
Affinity DataIC50: 30.4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280338BDBM280338((S)-4-(2-(5-chloro-2-fluorophenyl)-5-(prop-1-en-2-...)
Affinity DataIC50: 31.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280337BDBM280337((S)-4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropyl-4...)
Affinity DataIC50: 32.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280356BDBM280356(4-[[2-amino-6-(5-chloro-2-fluoro-phenyl)-3-isoprop...)
Affinity DataIC50: 33.1nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280344BDBM280344((S)-4-(2-(5-chloro-2-fluorophenyl)-5-ethylpyridin-...)
Affinity DataIC50: 33.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280351BDBM280351(4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropyl-4-pyr...)
Affinity DataIC50: 34.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280350BDBM280350(4-[[2-(5-chloro-2-fluoro-phenyl)-5-(1-methoxy-1-me...)
Affinity DataIC50: 40.1nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280361BDBM280361(4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropenyl-4-p...)
Affinity DataIC50: 40.2nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280349BDBM280349((S)-4-(2-(5-chloro-2-fluorophenyl)-5-(dimethylamin...)
Affinity DataIC50: 42.2nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280339BDBM280339((S)-4-(2-(5-chloro-2-fluorophenyl)-5-(prop-1-en-2-...)
Affinity DataIC50: 42.4nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280347BDBM280347(N-(2-acetamidoethyl)-4-[[2-(5-chloro-2-fluoro-phen...)
Affinity DataIC50: 45.1nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280338BDBM280338((S)-4-(2-(5-chloro-2-fluorophenyl)-5-(prop-1-en-2-...)
Affinity DataIC50: 45.2nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280350BDBM280350(4-[[2-(5-chloro-2-fluoro-phenyl)-5-(1-methoxy-1-me...)
Affinity DataIC50: 50.8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280342BDBM280342(4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropenyl-4-p...)
Affinity DataIC50: 53.9nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280355BDBM280355(4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropyl-4-pyr...)
Affinity DataIC50: 56.7nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280357BDBM280357(4-[[2-(5-chloro-2-fluoro-phenyl)-5-isopropenyl-4-p...)
Affinity DataIC50: 65.3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280346BDBM280346(4-[[2-(5-chloro-2-fluoro-phenyl)-5-methoxy-4-pyrid...)
Affinity DataIC50: 71.5nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280368BDBM280368(2-(5-chloro-2-fluorophenyl)-5-(prop-1-en-2-yl)-N-[...)
Affinity DataIC50: 77.3nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280367BDBM280367(4-{[2-(5-chloro-2-fluorophenyl)-5-(pyrrolidin-1-yl...)
Affinity DataIC50: 78.8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

TargetActivin receptor type-1B(Human)
Medivation Technologies

US Patent
LigandChemical structure of BindingDB Monomer ID 280344BDBM280344((S)-4-(2-(5-chloro-2-fluorophenyl)-5-ethylpyridin-...)
Affinity DataIC50: 86.8nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2022
Entry Details
US Patent

Displayed 1 to 50 (of 207 total ) | Next | Last >>
Jump to: